China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received regulatory clearance...
China-based InnoCare Pharma (HKG: 9969, SHA: 688428) announced that it has obtained regulatory approval from...
Shenzhen Chipscreen Biosciences Co., Ltd. (SHA: 688321) has revised its private placement proceeds to RMB...
Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) announced that it has received another...
China-based Innovent Biologics, Inc. (HKG: 1801) announced that it has received another indication approval from...
China-based CSPC Pharmaceutical Group Ltd. (HKG: 1093) has obtained approval from China’s National Medical Products...
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) announced that its subsidiary Chengdu Shetai Medical...
China-based Shanghai Henlius Biotech Inc., (HKG: 2696) has entered into a licensing agreement with South...
China’s Ministry of Industry and Information Technology, Ministry of Commerce, National Health Commission (NHC), and...
China-based Zhejiang Jolly Pharmaceutical Co., Ltd. (SHE: 300181) announced an investment of RMB 20 million...
US giant Johnson & Johnson (J&J; NYSE: JNJ) announced that it has received another indication...
Shenzhen-based LTZ Therapeutics has reportedly raised USD 40 million in a Series A+ financing round...
US biotech leader Amgen (NASDAQ: AMGN) announced a USD 900 million investment to expand its...
US giant Johnson & Johnson (J&J; NYSE: JNJ) announced that it has received regulatory approval...
China-based Keymed Biosciences Inc. (HKG: 2162) announced that it has received approval from the National...
China-based Akeso, Inc. (HKG: 9926) announced that its supplementary New Drug Application (sNDA) for ivonescimab,...
China-based Hefei Lifeon Pharmaceutical Co., Ltd (SHE: 003020) announced that it has received clinical trial...
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) announced that it has received clearance from...
China-based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) announced that its joint venture with...
China-based Juventas Cell Therapy Ltd announced that its chimeric antigen receptor (CAR)-T cell therapy, inaticabtagene...